Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
Public ClinicalTrials.gov record NCT00556075. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Three-Arm, Parallel Design, Dose-Ranging Placebo-Controlled, Randomized, Double-Blind, Multicenter Study Evaluating the Safety and Efficacy of Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
Study identification
- NCT ID
- NCT00556075
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Repros Therapeutics Inc.
- Industry
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Interventions
- Proellex 25 mg Drug
- Placebo Drug
- Proellex 50 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 48 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2007
- Primary completion
- Apr 30, 2009
- Completion
- Jun 30, 2009
- Last update posted
- Aug 24, 2014
2007 – 2009
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Clinical Therapeutics, LLC | Tucson | Arizona | 85712 | — |
| Lynn Institute of the Ozarks | Little Rock | Arkansas | 72205 | — |
| Medical Center for Clinical Research | San Diego | California | 92108 | — |
| Compass Clinical Research | San Ramon | California | 94583 | — |
| Altus Research | Lake Worth | Florida | 33461 | — |
| Comprehensive Clinical Trials | West Palm Beach | Florida | 33409 | — |
| Medical Associates | Dubuque | Iowa | 52002 | — |
| Physicians for Women | Cary | North Carolina | 27511 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Rapid Medical Research, Inc. | Cleveland | Ohio | 44122 | — |
| HWC Women's Research Center | Miamisburg | Ohio | 45342 | — |
| SC Clinical Research Center, LLC | Columbia | South Carolina | 29201 | — |
| Gaffney Pharmaceutical Research | Gaffney | South Carolina | 29340 | — |
| Greenville Pharma Research | Greenville | South Carolina | 29615 | — |
| Advanced Research Associates | Corpus Christi | Texas | 78414 | — |
| Clinical Trials of Texas/Institute for Women's Health | San Antonio | Texas | 78229 | — |
| Clinical Trials of Texas/Seven Oaks Women's Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00556075, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2014 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00556075 live on ClinicalTrials.gov.